8-K filed March 28, 2024, 7:59 PM ET ticker DYAI CIK 0001213809

earnings confidence high sentiment neutral materiality 0.70

Dyadic reports FY2023 net loss of $6.8M; appoints new Chairman and COO

DYADIC INTERNATIONAL INC

Net loss $6.8M ($0.24/share) vs $9.7M loss in 2022; revenue $2.9M flat YoY.
Cash & investments $7.3M at Dec 31, 2023; raised $6M convertible note in March 2024.
Positive Phase 1 topline data for DYAI-100 COVID booster: safe and immunogenic.
Patrick Lucy appointed Chairman, replacing Michael Tarnok (retiring June 2025); Joseph Hazelton named COO.
Entered multiple funded collaborations including top-ten pharma, Phibro/Abic, Rabian, Massachusetts General Hospital.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Barry C. Buckland

Director

DYAI · DYADIC INTERNATIONAL INC

Filed: March 28, 2024, 7:59 PM ET

Dr. Barry C. Buckland notified the Board of his decision to retire as a director of the Board, effective at the Company’s annual meeting to be held in June 2024.

Appointed

Joseph Hazelton

Chief Operating Officer

DYAI · DYADIC INTERNATIONAL INC

Effective: 2024-03-26
Filed: March 28, 2024, 7:59 PM ET

the Board appointed Joseph Hazelton, its current Chief Business Officer, to the position of Chief Operating Officer, effective immediately.

Appointed

Patrick Lucy

Chairman of the Board

DYAI · DYADIC INTERNATIONAL INC

Effective: 2024-03-26
Filed: March 28, 2024, 7:59 PM ET

appointed current member of the Board Patrick Lucy as its Chairman

Departed

Michael Tarnok

Director

DYAI · DYADIC INTERNATIONAL INC

Successor: Patrick Lucy
Filed: March 28, 2024, 7:59 PM ET

Mr. Tarnok notified the Board of his decision to retire as a director of the Board, effective at the Company’s annual meeting to be held in June 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barry C. Buckland retired as Director at DYADIC INTERNATIONAL INC.

Action: retired
Role: Director

Exact text from the filing

Dr. Barry C. Buckland notified the Board of his decision to retire as a director of the Board, effective at the Company’s annual meeting to be held in June 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Hazelton was appointed as Chief Operating Officer at DYADIC INTERNATIONAL INC.

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

the Board appointed Joseph Hazelton, its current Chief Business Officer, to the position of Chief Operating Officer, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Lucy was appointed as Chairman of the Board at DYADIC INTERNATIONAL INC.

Action: appointed
Role: Chairman of the Board

Exact text from the filing

appointed current member of the Board Patrick Lucy as its Chairman

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Tarnok retired as Director at DYADIC INTERNATIONAL INC.

Action: retired
Role: Director

Exact text from the filing

Mr. Tarnok notified the Board of his decision to retire as a director of the Board, effective at the Company’s annual meeting to be held in June 2025.

View on SEC.gov

DYADIC INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-24-009820

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.